Oxycodon 1 A Pharma (Oxycodone Hydrochloride Ph. Eur.)

Oxycodone Hydrochloride is used in the management of pain across several clinical pathways.

• Acute postoperative pain: Provides rapid relief of pain following surgery.
• Cancer‑related pain: Helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: Used when pain is moderate to severe and other treatments have failed.
• Trauma‑related pain: Alleviates severe pain from injuries such as fractures or burns.
• Palliative care: Improves comfort in end‑of‑life situations.

• Oxycodone binds to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor interaction also modulates neurotransmitter release, contributing to its analgesic effect while producing typical opioid‑related central effects.

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects

• Constipation: Reduced gastrointestinal motility leading to hard stools.
• Nausea: Sensation of queasiness often accompanied by vomiting.
• Drowsiness: Generalized sedation and reduced alertness.
• Dizziness: Light‑headed feeling, especially when standing quickly.
• Dry mouth: Decreased salivation causing oral discomfort.
• Pruritus: Itching without rash, often mild.

Serious or Rare Side Effects

• Respiratory depression: Markedly slowed breathing that can be life‑threatening.
• Severe hypotension: Dangerous drop in blood pressure.
• Opioid use disorder: Development of dependence or addiction.
• Seizures: Uncommon but possible neurological events.
• Anaphylaxis: Acute allergic reaction with airway compromise.
• adrenal insufficiency: Rare hormonal imbalance affecting stress response.

When prescribing oxycodone, clinicians should consider several safety measures.

• Assess pain severity: Confirm that pain is moderate to severe and other analgesics are inadequate.
• Evaluate patient history: Review prior opioid use, substance abuse, and respiratory conditions.
• Monitor for sedation: Observe for excessive drowsiness or impaired cognition.
• Adjust for renal/hepatic impairment: Dose may need modification in organ dysfunction.
• Educate on dependence risk: Inform patients about signs of tolerance and addiction.
• Store below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone can interact with various medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• CNS depressants: Concurrent use with benzodiazepines or barbiturates may cause profound respiratory depression.
• MAO inhibitors: May precipitate severe hypertension or serotonin syndrome.
• CYP3A4 inhibitors: Drugs like ketoconazole can increase oxycodone plasma levels, raising overdose risk.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors: Medications such as fluoxetine may reduce conversion to active metabolites, affecting analgesia.
• Anticholinergics: May exacerbate constipation.
• Diuretics: Can increase risk of hypotension when combined with oxycodone’s vasodilatory effects.